DocGo Q2 2024 GAAP EPS $0.06 Misses $0.07 Estimate, Sales $164.950M Beat $162.633M Estimate
Portfolio Pulse from Benzinga Newsdesk
DocGo (NASDAQ:DCGO) reported Q2 2024 earnings per share (EPS) of $0.06, missing the analyst consensus estimate of $0.07 by 14.29%. However, the company reported sales of $164.950 million, beating the analyst consensus estimate of $162.633 million by 1.42%. This represents a 31.45% increase over sales of $125.487 million in the same period last year.
August 07, 2024 | 9:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
DocGo's Q2 2024 EPS missed estimates by 14.29%, but sales beat expectations and increased by 31.45% year-over-year.
While the EPS miss might concern some investors, the significant year-over-year sales growth and the beat on sales estimates could offset the negative sentiment. The mixed results are likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100